Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 4
2006 3
2007 1
2008 2
2016 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.
Barone C, Grillo R, Dongiovanni D, Birocco N, Rampino M, Redda MG, Garibaldi E, Munoz F, Pecorari G, Cavalot A, Garzinodemo P, Buffoni L, Ciuffreda L, Ricardi U, Cortesina G, Giordano C, Fasolis M, Berrone S, Bertetto O, Schena M. Barone C, et al. Among authors: dongiovanni d. Anticancer Res. 2008 Mar-Apr;28(2B):1285-91. Anticancer Res. 2008. PMID: 18505067 Free article. Clinical Trial.
Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)?
Dongiovanni D, Daniele L, Barone C, Dongiovanni V, Fissore C, Sapino A, Macrì L, Bussolati G, Buffoni L, Gaspari F, Grillo R, Birocco N, Addeo A, Ciuffreda L, Schena M. Dongiovanni D, et al. Lung Cancer. 2008 Jul;61(1):73-81. doi: 10.1016/j.lungcan.2007.12.007. Epub 2008 Feb 19. Lung Cancer. 2008. PMID: 18243402 Clinical Trial.
G1 cell-cycle arrest and apoptosis by histone deacetylase inhibition in MLL-AF9 acute myeloid leukemia cells is p21 dependent and MLL-AF9 independent.
Tonelli R, Sartini R, Fronza R, Freccero F, Franzoni M, Dongiovanni D, Ballarini M, Ferrari S, D'Apolito M, Di Cola G, Capranico G, Khobta A, Campanini R, Paolucci P, Minucci S, Pession A. Tonelli R, et al. Among authors: dongiovanni d. Leukemia. 2006 Jul;20(7):1307-10. doi: 10.1038/sj.leu.2404221. Epub 2006 Apr 13. Leukemia. 2006. PMID: 16617320 No abstract available.
Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens.
Daniele L, Macrì L, Schena M, Dongiovanni D, Bonello L, Armando E, Ciuffreda L, Bertetto O, Bussolati G, Sapino A. Daniele L, et al. Among authors: dongiovanni d. Mol Cancer Ther. 2007 Apr;6(4):1223-9. doi: 10.1158/1535-7163.MCT-06-0719. Epub 2007 Apr 3. Mol Cancer Ther. 2007. PMID: 17406029 Free article.
Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial.
Dongiovanni V, Buffoni L, Berruti A, Dongiovanni D, Grillo R, Barone C, Addeo A, Fissore C, Bertetto O. Dongiovanni V, et al. Among authors: dongiovanni d. Cancer Chemother Pharmacol. 2006 Aug;58(2):203-9. doi: 10.1007/s00280-005-0157-6. Epub 2005 Dec 6. Cancer Chemother Pharmacol. 2006. PMID: 16331497 Clinical Trial.
Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
Schena M, Barone C, Birocco N, Dongiovanni D, Numico G, Colantonio I, Bertetto O. Schena M, et al. Among authors: dongiovanni d. Cancer Chemother Pharmacol. 2005 Mar;55(3):271-6. doi: 10.1007/s00280-004-0875-1. Epub 2004 Nov 16. Cancer Chemother Pharmacol. 2005. PMID: 15592837 Clinical Trial.
12 results